Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
12
Bearish filings
1
Named actors
6
Disclosed $ (bull / bear)
$1.1M / $0
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-04-30 | 5%+ holder (13G) VANGUARD CAPITAL MANAGEMENT LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-02-10 | Issuer (buyback) | announced a buyback | — | SEC ↗ |
| 2026-02-04 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-01-08 | 5%+ holder (13G) Marex Securities Products Inc. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2025-12-23 | Chief Executive Officer MARSHALL ALLAN | bought | $90K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2025-12-16 | Chief Executive Officer MARSHALL ALLAN | bought | $103K | SEC ↗ |
| 2025-12-15 | Chief Executive Officer MARSHALL ALLAN | bought | $207K | SEC ↗ |
| 2025-11-20 | Director Salkind Gene | bought | $127K | SEC ↗ |
| 2025-11-17 | Director Salkind Gene | bought | $265K | SEC ↗ |
| 2025-11-17 | Director Salkind Gene | bought | $281K | SEC ↗ |
| 2025-11-14 | Issuer (buyback) | announced a buyback | — | SEC ↗ |
| 2025-11-14 | 5%+ holder (13G) Polar Asset Management Partners Inc. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2025-10-16 | 5%+ holder (13G) Attestor Value Master Fund, LP | disclosed a passive stake (13G) | — | SEC ↗ |